Journal of Interferon & Cytokine Research 2005-07-01

Antiproliferative properties of chemically modified recombinant IFN-alpha2b.

A V Martynov, M V Smelyanskaya

Index: J. Interferon Cytokine Res. 25(7) , 414-7, (2005)

Full Text: HTML

Abstract

The antiproliferative activity of aconitylated (AIFN) and succinylated (SIFN) derivatives of recombinant interferon- alpha2b (IFN-alpha2b) was examined. Acylation of IFN-alpha2b was performed by succinic and cis-aconitic anhydrides. Antiproliferative properties of AIFN and SIFN were studied in vitro on the CaOv cell line, highly sensitive to IFN, and on the SW-480 cell line, with low sensitivity to IFN-alpha2b. Acylation of one lysine in the IFN-alpha2b molecule with cis-aconitic or succinic anhydride resulted in a 3-3.5-fold increase of its antiproliferative activity on CaOv cells. The highest antiproliferative activity of acylated IFN-alpha2b on SW-480 cells was observed for both AIFNs and SIFNs with three modified lysine residues. In conclusion, aconitylated and succinylated IFNs may be useful antiproliferative agents for cancer treatment.


Related Compounds

Related Articles:

Enhanced shRNA delivery and ABCG2 silencing by charge-reversible layered nanocarriers.

2015-02-25

[Small 11(8) , 952-62, (2015)]

Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.

2015-05-01

[Drug Deliv. 22 , 389-99, (2015)]

Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.

2015-12-01

[Colloids Surf. B Biointerfaces 136 , 365-74, (2015)]

Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.

2009-01-01

[J. Neuroinflammation 6 , 31, (2009)]

Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells.

1998-07-01

[Pharm. Res. 15(7) , 1031-7, (1998)]

More Articles...